Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Abroad (travel likely)RecruitingPHASE2
Conditions
Multiple Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Johns Hopkins University, Baltimore, Maryland, United States
Contact: Principal Investigator (Ellen Mowry, MD, MCR)
Study leads
Ellen M Mowry, MD, MCR
Principal Investigator
Johns Hopkins University